deltatrials
Unknown NA INTERVENTIONAL 2-arm NCT05405374

OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study (SELECT)

A Prospective, Randomized, Intra-Patient Controlled, Multi-Center Clinical Investigation Evaluating OSTEOAMP SELECT Fibers Versus Infuse Bone Graft as Autograft Substitute in Lumbar Fusion Procedures

Sponsor: Bioventus LLC

Interventions Infuse OSTEOAMP
Updated 7 times since 2022 Last updated: Aug 25, 2023 Started: May 6, 2022 Primary completion: Oct 31, 2024 Completion: Oct 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Degenerative Disc Disease and Lumbar Spine Disease, this trial is ongoing. The trial is conducted by Bioventus LLC and has accumulated 7 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshotRecruiting~Sep 2022 – ~Jan 2023 · 4 months · monthly snapshotRecruiting~Jan 2023 – ~Sep 2023 · 8 months · monthly snapshotRecruiting~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Dec 2025 · 15 months · monthly snapshotRecruiting~Dec 2025 – present · 7 months · monthly snapshotUnknown

Change History

7 versions recorded
  1. Dec 2025 — Present [monthly]

    Unknown NA

    Status: RecruitingUnknown

  2. Sep 2024 — Dec 2025 [monthly]

    Recruiting NA

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  4. Sep 2023 — Jul 2024 [monthly]

    Recruiting NA

  5. Jan 2023 — Sep 2023 [monthly]

    Recruiting NA

Show 2 earlier versions
  1. Sep 2022 — Jan 2023 [monthly]

    Recruiting NA

  2. Jul 2022 — Sep 2022 [monthly]

    Recruiting NA

    First recorded

May 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bioventus LLC
Data source: Bioventus LLC

For direct contact, visit the study record on ClinicalTrials.gov .